You have 9 free searches left this month | to do more

cirmtuzumab

Cirmtuzumab is a drug used to treat Chronic Lymphocytic Leukemia and Metastatic Castration-resistant Prostate Cancer. Cirmtuzumab is being actively studied in 2 studies and prior, has been studied in 2.

Top SponsorsTop SitesTop Investigators
University of California, San DiegoUC San Diego Moores Cancer CenterBenjamin Heyman
Thomas KippsUCSD Koman Family Outpatient PavilionCatriona Jamieson
UCSD Moores Cancer CenterRana Mckay
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Study of Docetaxel Combined With Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Cirmtuzumab
  • La Jolla, California
    University of California San Diego
2021-12-15
Dec 15, 2021
U
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
Recruiting
  • Chronic Lymphocytic Leukemia
  • San Diego, California
    UCSD Koman Family Outpatient Pavilion
2021-11-24
Nov 24, 2021
T
UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia - 2018
Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • cirmtuzumab
  • La Jolla, California
    UCSD Moores Cancer Center
2020-07-29
Jul 29, 2020
U
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961 - 2018
Completed
  • Chronic Lymphocytic Leukemia
  • cirmtuzumab
  • La Jolla, California
    UC San Diego Moores Cancer Center
2019-03-18
Mar 18, 2019